Research Article

New Insights into the Role of Metformin Effects on Serum Omentin-1 Levels in Acute Myocardial Infarction: Cross-Sectional Study

Table 1

Clinical and metabolic characteristics of the patients with type II DM at coronary care unit.

Characteristics Number (%), mean ± SD

Age (years)57.5 ± 12.02
Male : female ratio60% male, 40% female
Race, white : black ratio100 : 0
Onset of chest pain (hrs)4.42 ± 2.69 (1–7)
Positive history for IHD70 (82.35)
Hypertension69 (81.17)
Hyperlipidemia79 (92.94)
Duration of hospitalization6 ± 2.27 (4–10)
Troponin I positive42 (95.45)
Troponin negative2 (4.54)
Types of MI
 Anterior39 (45.88)
 Anteroseptal12 (14.11)
 Anterolateral 13 (15.29)
 Posterior14 (16.47)
 Inferior7 (6.81)
Complications12 (14.11)
 Death2 (2.35)
 Arrhythmia7 (8.23)
 Shock1 (1.17)
 Acute heart failure2 (2.35)
Pharmacotherapy
 Antiplatelets85 (100)
 Anticoagulant55 (64.70)
 Anti-ischemic78 (91.76)
 Antidiabetic agents85 (100)
  Metformin 62 (72.94)
  Others23 (27.05)
ACEI80 (94.11)
Hypolipidemic agents78 (91.76)
Analgesics22 (50)
Direct current shock (DC) 6 (70.58)

ACEI: angiotensin converting enzyme inhibitor.